Cutler Group LP Recursion Pharmaceuticals, Inc. Transaction History

Cutler Group LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$6.59 - $15.86 $1,318 - $3,172	-200 Reduced 66.67%	100 $0
Q2 2023 Jul 18, 2023	BUY	$4.56 - $9.94 $1,367 - $2,982	300 New	300 $2,000
Q4 2022 Feb 07, 2023	SELL	$7.16 - $12.7 $716 - $1,270	-100 Reduced 10.0%	900 $6,000
Q2 2022 Aug 04, 2022	SELL	$5.04 - $9.26 $705 - $1,296	-140 Reduced 12.28%	1,000 $8,000
Q4 2021 Jan 18, 2022	SELL	$16.14 - $21.86 $7,424 - $10,055	-460 Reduced 28.75%	1,140 $19,000
Q3 2021 Oct 26, 2021	BUY	$19.03 - $41.33 $30,448 - $66,128	1,600 New	1,600 $36,000

291

242M

1.35M

2.32M

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.24B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.